Group | Variable | Before Mean (SD) | After Mean (SD) | P* |
---|---|---|---|---|
Control | Perceived efficacy | 19.66 (5.08) | 20.29 (4.98) | .26 |
Perceived response efficacy | 10.07 (2.69) | 10.40 (2.78) | .26 | |
Perceived Self-efficacy | 9.59 (3.36) | 9.89 (3.05) | .44 | |
Perceived threat | 18.80 (3.14) | 18.95 (3.72) | .71 | |
Perceived susceptibility | 8.43 (2.55) | 8.17 (2.16) | .35 | |
Perceived severity | 10.19 (1.94) | 10.76 (2.73) | .93 | |
Intention | 9.25 (3.80) | 9.63 (2.51) | .37 | |
Daily SSBs consumption (glasses) | 2.95 (2.54) | 2.43 (1.87) | .13 | |
Gain frame message | Perceived efficacy | 19.62 (4.51) | 22.43 (4.08) | < .001 |
Perceived response efficacy | 9.79 (2.56) | 11.31 (2.48) | < .001 | |
Perceived Self-efficacy | 9.80 (2.65) | 11.12 (2.39) | < .001 | |
Perceived threat | 18.36 (3.06) | 19.32 (3.47) | .023 | |
Perceived Susceptibility | 7.72 (2.88) | 7.57 (2.35) | .66 | |
Perceived severity | 10.64 (1.22) | 11.74 (2.57) | .001 | |
Intention | 9.09 (3.56) | 9.00 (3.69) | .83 | |
Daily SSBs consumption (glasses) | 2.31 (2.06) | 2.12 (2.11) | .54 | |
Loss frame message | Perceived efficacy | 20.24 (4.54) | 22.57 (4.78) | < .001 |
Perceived response efficacy | 10.45 (2.43) | 11.60 (2.47) | < .001 | |
Perceived Self-efficacy | 9.84 (3.37) | 10.95 (3.26) | .021 | |
Perceived threat | 18.01 (2.79) | 21.26 (3.67) | < .001 | |
Perceived Susceptibility | 7.85 (2.28) | 8.34 (2.12) | .07 | |
Perceived severity | 10.19 (1.52) | 12.86 (2.69) | < .001 | |
Intention | 8.90 (3.19) | 8.05 (3.04) | .04 | |
Daily SSBs consumption (glasses) | 3.00 (3.01) | 2.38 (1.73) | .16 |